United States · 
Who invested in Comet Therapeutics?
Comet Therapeutics's investors include Canaan, Sofinnova Partners, Mission BioCapital, Inkef and BioInnovation Capital. Canaan led its latest round.
United States · Series A startup
Who invested in Comet Therapeutics
Funding summaryUpdated 26 Oct 2026
$29Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $29MJun 2019
- Led by
- Canaan and Sofinnova Partners
- Investors
- 5 (2 led)
The rounds
- Jun 2019Series A$29M
Reported by FinSMEsSEC filing: $14M sold, first sale Jun 2019
Founders and team
From the SEC filings it signed: 3 on the team.
- Art TaverasExecutive Officeri
- David De GraafExecutive Officer, Directori
- Enej KuscerExecutive Officeri
On the board, as filediBernardus MachielseHenrijette RichterLucas De BreedPeter Van Vlasselaer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Comet Therapeutics
How much has Comet Therapeutics raised?
Comet Therapeutics has raised $29M across 1 round since 2019.
When did Comet Therapeutics last raise?
Comet Therapeutics's most recent round was a Series A of $29M in Jun 2019, led by Canaan.
What was Comet Therapeutics's biggest round?
Its most recent round, $29M in Jun 2019, is also its largest on record.
Who backed Comet Therapeutics first?
Comet Therapeutics's first round on record, in Jun 2019, was backed by Canaan, Sofinnova Partners and Mission BioCapital and 2 others.
What stage is Comet Therapeutics at?
Comet Therapeutics's latest named round is a Series A, in Jun 2019.
Where is Comet Therapeutics based?
Comet Therapeutics is based in the United States.
Who led Comet Therapeutics's rounds?
Canaan led the Series A in 2019.
Companies like Comet Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.